Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
CEO Spotlight: Gaston Salinas
Single-use Fermenters for Microbial Biopharma Development & Manufacturing
Creating Solutions for CDMOs: An EPCMV Firm’s Perspective
The Transformative Potential of Gene Therapy
Parenteral Perspectives
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Charles River Expands Contract Vivarium Space in Somerville
Aterian Investment Partners Acquires CPL
AstraZeneca Invests in Nucleus RadioPharma
Dalton Pharma Services Invests in Robotic Aseptic Powder Fill-Finish Line
Formosa Labs Completes Acquisition of Synchem
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
AstraZeneca Invests in Nucleus RadioPharma
Dalton Pharma Services Invests in Robotic Aseptic Powder Fill-Finish Line
Formosa Labs Completes Acquisition of Synchem
Why Are Uncertainty Factors and RRF Databases Important When Selecting an E&L Provider?
How National Resilience Inc. Fast-Tracked a GxP Training Infrastructure
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Thermo Fisher Opens New GMP Ultra-cold Facility in the EU
The Future of the Pharmaceutical Contract Packaging Industry
PDUFA to Patients in 7 Days with Integrated Packaging Solutions
Pharma Matters Q&A: PCI Pharma Services
Pharma Matters Q&A: Marken
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Charles River Expands Contract Vivarium Space in Somerville
EU Biotech Policy Changes Spark Debate
AstraZeneca Invests in Nucleus RadioPharma
Kindeva Expands Loughborough, UK Facilities
Charles River, Sanofi Partner to Reduce the Use of Animals in Research
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
How QMS Impacts Quality Maturity
Regulatory Affairs: Drug Shortages – No Solution in Sight!
Regulatory Affairs: A Common Warning Letter Citation Explored
The Future of Pharmacovigilance is Proactive
Parenteral Perspectives
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
AMERIPHARMA
LOTTE BIOLOGICS
BioTechnique
SUANFARMA CDMO
Vetter Pharma International
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
AMERIPHARMA
LOTTE BIOLOGICS
BioTechnique
SUANFARMA CDMO
Vetter Pharma International
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Search Results for '
hepatitis
'
Search For:
Refine by Dates:
From:
To:
Past 7 Days
|
Past 30 Days
Refine By Content:
All
Advanced Degrees
Ask The Board
Ask The Experts
Back Page
Bio News & Views
Blog
Breaking News
Business Corner
Buyers Guide Companies
Case Studies
Classifieds
Columns
Company Blog
Conference Sessions
Content Microsite
Ebook
Editorial
Executive Perspective
Expert's Opinion
FDA Watch
Features
Financial Analysis
Getting Results
Glossary
I Mak
India Report
Industry Events
Infographics
Jobs
Literature / Brochures
Live From Shows
Lowe Down
Managing Your Career
News Releases
Online Exclusives
Outsourcing Survey
Pharma Beat
Podcasts
Posters
Preclinical Outsourcing
Product Releases
Salary Survey
Services
Slideshows
Sponsored Content
Top 25 Pharma & BioPharma
Top Companies Report
Trials & Filings
Videos
Webinars
White Papers / Tech Papers
Biologics, Proteins, Vaccines
|
Breaking News
|
Drug Development
ARTES Biotech to Develop VLP SARS-CoV-2 Vax Candidates
Virus-like particles mimic the conformation of authentic native viruses without being infectious.
Contract Pharma Staff
04.27.20
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Industry News
Cytovance and Akshaya Enter Vaccine Collaboration
Partnership to focus on therapeutics for treatment of coronavirus and hepatitis B virus infections
Contract Pharma Staff
04.24.20
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Clinical Trials
|
Collaborations & Alliances
|
Drug Development
|
Industry News
GSK, Vir Biotechnology Enter Coronavirus Collaboration
Antibody candidates for SARS-CoV-2 to be accelerated into Phase II trials in the next 3-5 months; GSK to invest $250 million in Vir
Contract Pharma Staff
04.07.20
Bioanalytical Services
|
Breaking News
|
CRO News
QPS Assembles Access Restricted Bioanalysis Lab
CDC issues permit to handle and analyze COVID-19 Biohazard Safety Level-2 clinical trial samples
03.10.20
APIs
Drug Substance Cost: A Non-Issue?
Insight and implications of drug substance cost analysis.
Dr. Michele Jermini and Dr. Enrico Polastro
03.04.20
Breaking News
|
Collaborations & Alliances
|
CRO News
|
Industry News
|
R&D
Viroclinics and DDL Join Forces
Two virology testing laboratories integrate to form new group serving the global biopharmaceutical industry
03.03.20
Breaking News
|
Financial Reports
Financial Report: Gilead
Continued uptake of Biktarvy helps offset declines for other products
02.07.20
Drug Development
|
Promotions & Moves
Assembly Biosciences Appoints CMO
Dr. Stamm joins the company from Gilead where she was a senior member of the HCV and HIV clinical research teams
11.08.19
Contract Pharma’s 20th Anniversary Retrospective
A look back a the pharma/biopharma industry and the future of outsourcing.
Kristin Brooks, Managing Editor, Contract Pharma
10.15.19
Ionis Licenses Hepatitis B Program to GSK
Transaction provides Ionis with significant participation in the commercial success of HBV program
08.27.19
Promotions & Moves
Assembly Biosciences Appoints President and CEO
Dr. McHutchison is a world-renowned hepatologist, gastroenterologist, and anti-viral drug developer
08.07.19
Industry News
ContraVir Pharmaceuticals Becomes Hepion Pharmaceuticals
Trading Symbol Change to “HEPA”
07.24.19
Gilead Sciences
...
07.15.19
GlaxoSmithKline
...
07.15.19
AbbVie
...
07.15.19
Merck
...
07.15.19
11 Bristol-Myers Squibb
...
07.11.19
Financial Reports
Financial Report: Gilead
HIV franchise sales offset HCV declines
05.03.19
Breaking News
|
Collaborations & Alliances
|
Drug Development
TaiwanJ Inks $26M Deal with Newsoara
For licensing and co-development contract with Newsoara on JKB-122 Asian rights
03.12.19
Breaking News
|
Financial Reports
Financial Report: Gilead
HIV product sales were $4.1 billion in the quarter, up 21%
02.05.19
Breaking News
|
Promotions & Moves
Gilead Appoints CEO
Daniel O’Day of Roche Pharmaceuticals takes the helm March 1, 2019
12.14.18
Bio News
|
Clinical Trials
|
Collaborations & Alliances
|
Drug Discovery
|
Industry News
|
R&D
VBI, Brii Bio Partner for Hepatitis B
Brii Bio paid VBI $11 million upfront, including a $4 million upfront payment & a $7 million equity investment at $3 a share
12.06.18
APIs
|
Excipients
Pharmaceutical Fine Chemicals Trends
Moving toward a new order in the pharmaceutical fine chemical / CD&M industry?
Dr. Enrico T. Polastro, Vice President, Arthur D. Little Benelux SA/NV
11.13.18
Bioanalytical Services
Viral Contaminant Testing in Biopharma Manufacturing
There is no single test to detect all potential viral contaminants in biopharmaceutical manufacturing.
Richard Adair, Virology Manager, SGS Life Sciences, Glasgow, UK
11.13.18
Breaking News
|
Drug Development
|
Industry News
CASI Pharmaceuticals Acquires Laurus Lab's HBV Drug
Expands pipeline and mission to commercialize U.S. FDA approved drugs in China
10.23.18
Financial Reports
Financial Report: Bristol-Myers Squibb
Eliquis and Opdivo sales help offset declines for established products
08.01.18
Financial Reports
Financial Report: Gilead
HCV sales down 66% on the quarter
08.01.18
cGMP Manufacture
|
Industry News
|
Process Development
WuXi STA, Antengene Ink Mfg. Pact
WuXi STA will provide in process R&D and manufacturing services
07.24.18
08 AbbVie
...
07.20.18
05 Merck
...
07.20.18
04 Johnson & Johnson
...
07.20.18
14 Bristol-Myers Squibb
...
07.20.18
09 Gilead Sciences
...
07.20.18
Analytical Services
|
CRO News
|
Industry News
|
Laboratory Testing
|
Preclinical Outsourcing
BASi, Seventh Wave Labs Merge
Will join operations in an effort to provide broader solutions and expanded scientific expertise
07.02.18
APIs
|
Breaking News
|
Collaborations & Alliances
|
Industry News
|
Process Validation
|
Regulatory Affairs
WuXi STA Enables Ascletis to Receive NDA Approval from China FDA for Ganovo
Is first CDMO to support the approval of an innovative drug in China through the MAH pilot program
06.14.18
Financial Reports
Financial Report: Gilead
HCV Franchise takes a hit, down 59% in the quarter
05.10.18
Financial Reports
Financial Report: Bristol-Myers Squibb
Eliquis and Opdivo sales reach $1.5 billion in the quarter
05.09.18
Bio News
|
Clinical Trials
|
Formulation Development
|
Industry News
|
Promotions & Moves
Motif Bio Appoints Clinical Development VP
Stephanie Noviello, MD, MPH joins the company from Bristol Myers Squibb
05.09.18
Drug Development
The Immune System & Drug Development
Functions, challenges and effective approaches to safety assessment
Greg Bannish, Vice President, Biopharmaceutical Development, Envigo
05.08.18
Biologics, Proteins, Vaccines
|
Drug Development
The Beginning of a New Era?
The press heralded 2017 as a “breakthrough year for biotech.” Will CAR-T cell therapies usher in a new era of medicine?
Christoph Bieri, Managing Partner, Kurmann Partners
05.08.18
Biologics, Proteins, Vaccines
Newsmakers: SGS
Developing Next-Gen Vaccines
Tim Wright, Editor
05.07.18
Bio News
|
cGMP Manufacture
|
Collaborations & Alliances
|
Industry News
|
Regulatory Affairs
Nabriva, Roivant Enter License Agreement
To develop and commercialize lefamulin, for the treatment of community-acquired bacterial pneumonia, in greater China
03.27.18
Bio News
|
Drug Development
|
Drug Discovery
|
Industry News
|
Laboratory Testing
ContraVir Pharmaceuticals Receives Regulatory Shortcut
To streamline the development and registration of TXL for the treatment of Chronic Hepatitis B
02.12.18
Financial Reports
Financial Report: Gilead
HCV product sales down 53% in the quarter; $5.5 billion charge from U.S. Tax Reform results in loss
02.07.18
Bio News
|
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
|
Trials & Filings
CASI Acquires ANDA Portfolio From Sandoz
CASI intends to select and commercialize certain products from the portfolio
01.29.18
Promotions & Moves
Viriom Appoints Director
Lawlor brings extensive operating experience in strategic business development, finance, management of M&As
12.06.17
Financial Reports
Financial Report: Gilead
HCV product sales down 33% in the quarter
10.31.17
GMPs/GCPs
The Importance of GMP, GLP and GCP in the Safe Development of Viral Challenge Agents
Developing new challenge agents faster and at a lower cost.
Adrian Wildfire, Clinical Research
09.06.17
Clinical Trials
|
CRO News
|
Drug Development
Parcom Capital Acquires Viroclinics Biosciences
Expands vaccine testing capabilities
08.29.17
14 Bristol-Myers Squibb
...
07.24.17
Breaking News
Sartorius Opens New CoE for Bioanalytics in Ann Arbor
Charles River Expands Contract Vivarium Space in Somerville
Aterian Investment Partners Acquires CPL
AstraZeneca Invests in Nucleus RadioPharma
Dalton Pharma Services Invests in Robotic Aseptic Powder Fill-Finish Line
View Breaking News >
CURRENT ISSUE
May 2024
CDMOs: The Cornerstone of Biopharmaceutical Innovation
Pharma 4.0: CDMOs Digitalize to Enhance Customer Value
CEO Spotlight: Gaston Salinas
Parenteral Perspectives
The Transformative Potential of Gene Therapy
Cell & Gene Therapy Outsourcing
Creating Solutions for CDMOs: An EPCMV Firm’s Perspective
Single-use Fermenters for Microbial Biopharma Development & Manufacturing
View More >